INTRODUCING IPS: A PROGNOSTIC BIOMARKER FOR PATIENTS ON ICI THERAPY /// LEARN MORE INTRODUCING IPS: A PROGNOSTIC BIOMARKER FOR PATIENTS ON ICI THERAPY /// LEARN MORE
November 5 — 6, 2024 SAN DIEGO, CA

Exhibit Booth #414
Conference Session

World ADC 2024

Tempus is advancing precision medicine through the practical application of artificial intelligence in healthcare. We are pleased to attend the 15th annual World ADC San Diego conference and present on how Tempus’ biological modeling and RWD solutions can support antibody drug conjugate development.

Schedule a meeting with us
Conference Session
November 6, 2024
live session
Time
11:30am-12:00pm PT
Location
Town & Country Resort
500 Hotel Circle North
San Diego, CA 92108

Presenters
Tim Hagerty, PhD
VP, Life Science Strategy (Tempus)

Richard Klinghoffer, PhD
SVP, Head of Systems Biology (Tempus)

Bridging Preclinical Models and Clinical Success: Leveraging PDOs & RWD to Advance ADC Development

A part of the ‘Translational’ track

  • Application of RWD to identify novel therapeutic targets and provide insights into responder populations for ADC development
  • Examine how patient-derived organoids (PDOs) can enhance biomarker validation and help guide therapeutic decisions.
  • Bringing it all together: Highlighting a “lab-in-the-loop” approach to incorporate screening panels of PDOs – optimized for ADC evaluation – and RWD to enhance biomarker validation and guide pipeline prioritization.

Read more

Schedule a meeting with us

We'll be in touch shortly.